Letter to the editor regarding "At Birth, Tales of Joy and Heartbreak"
By Marcy Darnovsky,
New York Times
| 10. 14. 2009
To the Editor:
“The Gift of Life, and Its Price” reports that the fertility industry’s professional organization encourages its members to transfer fewer embryos, so as to produce fewer multiple pregnancies and premature babies. The organization, the American Society for Reproductive Medicine, is to be commended for these efforts.
But its guidelines are routinely flouted. The society could put teeth behind its rules by publicly suspending the memberships of fertility practices in noncompliance. And it has resisted calls for public regulation and oversight.
Recent experiences with the financial sector have dramatized the dangers of inadequate public policy. The fertility industry, too, demonstrates the limits of self-regulation. Public regulation must be carefully written and not used to advance other agendas like opposition to reproductive rights. It’s past time for the federal government to set rules for the fertility industry and establish ways to enforce them.
Marcy Darnovsky
Berkeley, Calif., Oct. 11, 2009
The writer is associate executive director of the Center for Genetics and Society.
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...